Study: Constituent of TCM Coptis Chinensis Is a Potential Treatment for Lung Cancer

Study has pointed out that berberine, an active ingredient extracted from the TCM Coptis chinensis, has the potential to become a potential treatment of lung cancer. Shutterstock

Lung cancer is the most common and fatal cancer. In 2020, there were more than 2 million new lung cancer cases and 1.79 million deaths worldwide. The latest research pointed out that berberine, an active ingredient extracted from the Traditional Chinese Medicine (TCM) Coptis chinensis, has anti-cancer effects.

The research team converted them into berberine-phytantriol-loaded liquid crystalline nanoparticles (BP-LCN), and it is hoped to become a treatment for lung cancer.